Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The first outbreak of cVDPV was identified in the Dominican Republic and Haiti between 2000 and 2001.”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“In general, the VP1 sequences examined from cVDPV isolates differed from parental OPV strains by only 1–3.5%, suggesting that reversion to the attenuated phenotype of Sabin strains occurs with circulation times of 1–4 years [91,92,93,95,100].”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [91]
In the citing paper
“As with the other epidemics in Egypt and Hispaniola, VDPV circulated in a province of Madagascar with low OPV coverage (6,7).”
From Recombinant Vaccine–Derived Poliovirus in Madagascar (2003) · cites this paper as [7]
In the citing paper
“Most VDPV strains described as OPV/HEV-C recombinants were isolated in countries in which wild PVs have been eradicated”
From Co-Circulation and Evolution of Polioviruses and Species C Enteroviruses in a District of Madagascar (2007) · cites this paper as [12]
In the citing paper
“The cVDPV had recovered two of the most important biological properties of wild PV: the capacity to cause severe paralytic disease in humans and the capacity for extensive human-to-human transmission.”
From Recombination between Poliovirus and Coxsackie A Viruses of Species C: A Model of Viral Genetic Plasticity and Emergence (2011) · cites this paper as [83]
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oberste, M. S., Maher, K., Kilpatrick, D. R., & Pallansch, M. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1941-1948.1999 · Cited by 866
Self-citationStrebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Self-citationKawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232
NATHANSON, N., & MARTIN, J. R. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112848 · Cited by 214
Antigenic Structure of Picornaviruses
Minor, P. D. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75602-3_5 · Cited by 187
Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence
Gromeier, M., Bossert, B., Arita, M., Nomoto, A., & Wimmer, E. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.958-964.1999 · Cited by 160
Molecular epidemiology of polioviruses
Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157
Self-citationDeterminants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine
Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140
Comparative study of five methods for intratypic differentiation of polioviruses
van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122
Self-citationMinor, P. D., & Dunn, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-5-1091 · Cited by 120
Research works printed but not linked: 5
- Andrus J. K., Strebel P. M., de Quadros C. A., Olive J. M., Bull. WHO 73, 33 (1995).
- Supplementary figures and details of experimental procedures are available on Science Online at www.sciencemag.org/cgi/content/full/1068284/DC1.
- Minor P. D., Curr. Top. Microbiol. Immunol. 161, 121 (1990).
- ___, Morb. Mortal. Wkly. Rep. 50, 41 (2001).
- Wood D. J., Sutter R. W., Dowdle W. R., Bull. WHO 78, 347 (2000).
Cited by
Items 401–500 of 594
Determination of poliovirus-specific IgA in saliva by ELISA tests
Ap, I., Dragunsky, E. M., Ivanova, O. E., Rezapkin, G. V., Potapova, S., & Chumakov, K. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.01.030 · Cited by 8
Antiviral Development for the Polio Endgame: Current Progress and Future Directions
Xie, H., Rhoden, E. E., Liu, H., Ogunsemowo, F., Mainou, B. A., Burke, R. M., & Burns, C. C. (2024) · Pathogens · doi:10.3390/pathogens13110969 · Cited by 9
“…an OPV in the gut could also lead to the reversion of virulence and allow the shedding of vaccine-derived polioviruses (VDPVs), which can spread among populations with low vaccine coverage, leading to circulating vaccine-derived polioviruses (cVDPVs) that can cause outbreaks of paralysis [12,13].”
Self-citationShulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5719-0_10 · Cited by 7
“For examples of such recombinations see molecular analyses of isolates from the cVDPV outbreaks in Haiti and Dominican Republic [90] and Indonesia [91] and in individual cases [92].”
BackgroundOkonko, I. O., Babalola, E. T., Adedeji, A. O., Onoja, A. B., Ogun, A. A., Nkang, A. O., & Adu, F. D. (2008) · Biotechnology and Molecular Biology Reviews · doi:10.5897/bmbr2008.0012 · Cited by 8
KITAMURA, K., & Shimizu, H. (2022) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2022.312 · Cited by 7
Self-citationUeno, M. K., KITAMURA, K., Nishimura, Y., & Arita, M. (2023) · Viruses · doi:10.3390/v15102113 · Cited by 7
“While the analysis of the VP1 region is essential for the ITD, which could detect circulating VDPV (cVDPV) and trigger a vaccine campaign [11–13], the VP4–VP2 region is useful for sensitive detection of enteroviruses, including PV [7,9,10].”
Chapter 1 Molecular Virology of Rubella Virus
Chen, M., & Icenogle, J. P. (2006) · Perspectives in medical virology · doi:10.1016/s0168-7069(06)15001-6 · Cited by 7
Inactivated Polio Vaccine: its proposed role in the final stages of polio eradication
Davis, R., & Biellik, R. (2013) · Pan African Medical Journal · doi:10.11604/pamj.2013.14.102.2580 · Cited by 8
“In 2000, the island of Hispaniola, home to Haiti and the Dominican Republic, was the first place where the existence of circulating vaccine derived poliovirus (cVDPV) was demonstrated [1].”
BackgroundPolio, Still Lurking in the Shadows
van den Pol, A. N. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2861-12.2013 · Cited by 10
Friedman, S. D., Snellgrove, W. C., & Genthner, F. J. (2012) · Viruses · doi:10.3390/v4091548 · Cited by 11
“Poliovirus recombination occurs in vaccine-derived strains [24] in the”
BackgroundHassan, J., Wangai, L. N., Borus, P., Khayeka‐Wandabwa, C., Karani, L. W., Kithinji, M., & Kiptoo, M. K. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2843-y · Cited by 10
Pedreira, C., Thrush, E. C., Rey-Benito, G. J., Chévez, A. E., & Jaúregui, B. (2017) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2017.154 · Cited by 7
“Landaverde M, Venczel L, de Quadros C. Poliomyelitis outbreak caused by vaccine-derived virus in Haiti and the Dominican Republic.”
BackgroundInfluentialSelf-citationEnterovirus Infection in Immunocompromised Hosts
Schaenman, J. M. D., Ho, D. Y., Baden, L. R., & Safdar, A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_42 · Cited by 7
Post-polio syndrome: clinical manifestations and cerebrospinal fluid markers
Fiorini, M., Zanusso, G., Baj, A., Bertolasi, L., Toniolo, A., & Monaco, S. (2007) · Future Neurology · doi:10.2217/14796708.2.4.451 · Cited by 7
“This form has been found both in vaccinated subjects and in nonimmune individuals exposed to the live oral PV vaccine [4].”
BackgroundEnterovirus Infections, Including Poliomyelitis
Pallansch, M. A., & Jafari, H. S. (2006) · Elsevier eBooks · doi:10.1016/b978-0-443-06668-9.50065-x · Cited by 7
Self-citationDennehy, P. H., Jaeger, J. L., Losikoff, P. T., & Pugatch, D. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50260-0 · Cited by 7
HEYMANN, D. L., de Gourville, E. M., & Aylward, R. B. (2004) · Epidemiology and Infection · doi:10.1017/s0950268804002638 · Cited by 7
“Dominican Republic, 8 in Haiti) suggested that all cases were derived from a single OPV dose, estimated to have been given in late 1998 or early 1999 [3].”
BackgroundHietpas, J., McMullan, L. K., Hanson, H. L., Rice, C. M., & Mindell, D. P. (2005) · Elsevier eBooks · doi:10.1016/b978-012088483-4/50007-x · Cited by 8
“[6] [7] Reassortment can also occur when two related viruses with segmented genomes infect a single cell.”
BackgroundImmune status to poliovirus among immigrant workers in Israel
Calderon‐Margalit, R., Sofer, D., Gefen, D., LEWIS, M., SHULMAN, L., Mendelson, E., Swartz, T. A., & Shohat, T. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.09.008 · Cited by 6
Okonko, I. O., Ogun, A. A., Adedeji, A. O., Akanbi, O. A., Udeze, A. O., & Motayo, B. O. (2009) · Scientific Research and Essays · doi:10.5897/sre.9000269 · Cited by 9
Type I vaccine-derived polioviruses in China from 1995 to 2019
Zhang, Y., Zhu, S., Yan, D., Wang, D., Li, X., Zhu, H., An, H., & Xu, W. (2019) · Biosafety and Health · doi:10.1016/j.bsheal.2019.12.002 · Cited by 6
Enteroviruses, Parechoviruses, and Saffold Viruses
Krogstad, P. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00166-7 · Cited by 6
La polio, el largo camino hacia el final de la partida
García‐Sánchez, J. E., García-Sánchez, E., García-Merino, E., & Fresnadillo, M. J. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2014.10.005 · Cited by 16
Global efforts to eradicate polio.
Krym, V. F., & MacDonald, R. D. (2004) · Europe PMC (PubMed Central) · Cited by 6
The virology of the Polio virus
Adu, F. (2007) · Annals of Ibadan Postgraduate Medicine · doi:10.4314/aipm.v3i1.39072 · Cited by 6
Thys, B., Palma, A. M. D., Neyts, J. H., Andries, K., Vrijsen, R., & Rombaut, B. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.01.002 · Cited by 6
Dürrheim, D. N. (2022) · International Health · doi:10.1093/inthealth/ihac068 · Cited by 6
Wassilak, S. G. F., Mohamed, A., & Bigouette, J. P. (2025) · Vaccines · doi:10.3390/vaccines13101060 · Cited by 6
“The first reported cVDPV outbreak was cVDPV1 in Haiti and the Dominican Republic (Hispaniola) in 2000–2001 [112,147].”
Hörer, S., Burdak‐Rothkamm, S., Allers, K., Schneider, T., & Duchmann, R. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.08.001 · Cited by 5
Arbo, A., Falleiros-Arlant, L. H., López, E. L., del Castillo, J. B., de Cuéllar, C. M., Moreno, G., Rolón, R., Cerda, J., & Eguiazú, S. (2019) · Revista chilena de infectología · doi:10.4067/s0716-10182019000100083 · Cited by 5
Global Polio Eradication: Progress and Challenges
Bandyopadhyay, A. S., & Macklin, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-71165-8_30 · Cited by 8
Alirezaie, B., Taqavian, M., Aghaiypour, K., Esna‐Ashari, F., & Shafyi, A. (2011) · Journal of Medical Virology · doi:10.1002/jmv.21804 · Cited by 6
“…2000; Kew et al., 2005] and/or organisms (e.g., human/animal intestinal tract) [Melnick et al., 1959; MacLeod, 1966; Jarzabek et al., 1976, 1977; Kew et al., 1981, 2002, 2005; Evans et al., 1985; Hamada et al., 1988; Macadam et al., 1989; Dunn et al., 1990; Tatem et al., 1991; Contreras et al.,…”
Quasispecies Dynamics in Disease Prevention and Control
Domingo, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800837-9.00008-3 · Cited by 6
“Escape mutants may be direct mutants of the infecting virus or may originate by recombination between the infecting virus and other co-infecting related viruses, as observed with poliovirus and bovine herpesvirus-1 [Kew et al., 2002; Thiry et al., 2006 ; among other studies with these and additional viruses].”
BackgroundIsolation and Identification of Inter-Species Enterovirus Recombinant Genomes
Bentley, K., Tee, H. K., Pearson, A., Lowry, K., Waugh, S., Jones, S., Chan, Y. F., & Evans, D. J. (2021) · Viruses · doi:10.3390/v13122390 · Cited by 5
“Such changes are most notable when resulting in the emergence of novel viruses that increase the threat to animal or human health such as Western Equine Encephalitis virus [34], circulating vaccine-derived polioviruses [9,10], SARS coronavirus [35,36], and likely SARS-CoV-2, the causative agent of the COVID19 pandemic…”
BackgroundHealth Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame
Badizadegan, K., Kalkowska, D. A., & Thompson, K. M. (2023) · Medical Decision Making · doi:10.1177/0272989x231191127 · Cited by 5
“…can lead to loss of attenuating mutations and consequent outbreaks of circulating VDPVs (cVDPVs) that clinically behave like the homotypic WPVs. 3,17,18 Similarly, when immunodeficient individuals become prolonged or chronic excreters (and hence replicators) of live polioviruses following…”
BackgroundVacunas antipoliomielíticas: VPI frente a VPO
Ruíz-Contreras, J., & Merino, Á. H. (2003) · Anales de Pediatría · Cited by 5
Enterovirus and Parechovirus Infections
Cherry, J. D. (2006) · Elsevier eBooks · doi:10.1016/b0-72-160537-0/50026-8 · Cited by 7
Editorial: A farewell to polio vaccination? Not anytime soon
Razum, O. (2002) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.2002.00958.x · Cited by 5
“The cases had not been caused by imported wild polio viruses, as had initially been suspected, but by vaccine viruses of the Sabin strain; these had back-mutated, recovering the neurovirulence and high contagiousness of the polio wild virus (Kew et al. 2002).”
BackgroundCommentary: Poliomyelitis and unnecessary injections
Halsey, N. A. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg071 · Cited by 6
Sullivan, K. E., Bassiri, H., Bousfiha, A. A., Costa‐Carvalho, B. T., Freeman, A. F., Hagin, D., Lau, Y., Lionakis, M. S., Moreira, I., Pinto, J. A., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0436-0 · Cited by 5
“An example for such an event was demonstrated by the 2000-2001 outbreak in the Dominican Republic and Haiti [247] , believed to be driven at least in part by undervaccination of the population, which allowed the spread of the reverted vaccine strain [248] .”
BackgroundGenomic Characterization of Two Bovine Enterovirus Strains Isolated from Newly Transported Cattle
Wu, C., Zhong, S., Feng, S.-W., He, H., Hu, S., Chen, Z., Li, C., XiongBiao, X., Peng, H., Wei, Z., et al. (2025) · Veterinary Sciences · doi:10.3390/vetsci12070660 · Cited by 4
“When the Sabin attenuated vaccine strain is recombined with other EV epidemic strains, the new recombinant strain may have a strong neurovirulence and transmission ability, which may easily cause new outbreaks [31,32].”
Sehrawat, S., Osterrieder, N., Schmid, D. S., & Rouse, B. T. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105078 · Cited by 7
Discovery of vaccine-like recombinant SARS-CoV-2 circulating in human
He, D. C., & He, C.-Q. (2022) · Virology Journal · doi:10.1186/s12985-022-01945-5 · Cited by 4
“After in-depth research, it was found that these outbreaks were caused by the reversion of vaccine virulence because of the recombination of the spillover LAV with enteroviruses [9], which seriously interferes with the polio eradication plan.”
BackgroundTrallero, G., Cabrerizo, M., & Avellón, A. (2013) · Revista Española de Salud Pública · doi:10.4321/s1135-57272013000500006 · Cited by 4
Development of picornavirus-like particle vaccines
Somasundaram, B., & Lua, L. H. L. (2015) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.39 · Cited by 4
Introduction to the Enteroviruses and Parechoviruses
Modlin, J. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00170-3 · Cited by 4
Enterovirus Infections, Including Poliomyelitis
Pallansch, M. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00060-4 · Cited by 6
Self-citationChansaenroj, J., Chuchaona, W., Thanusuwannasak, T., Duang‐in, A., Puenpa, J., Vutithanachot, V., Vongpunsawad, S., & Poovorawan, Y. (2019) · VirusDisease · doi:10.1007/s13337-019-00515-8 · Cited by 4
Pliaka, V., Ruether, I. G. A., Kyriakopoulou, Z., Kioussi, P., Plakokefalos, E., Megalou, M., Pratti, A., Levidiotou-Stefanou, S., & Markoulatos, P. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03188.x · Cited by 4
Hovi, T., Savolainen‐Kopra, C., Smura, T., Blomqvist, S., Al‐Hello, H., & Roivainen, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066836 · Cited by 5
“01 substitutions per site per year in the capsid coding region [1,2,3,4,5,6,7,8,9,10].”
BackgroundAvellón, A., españoles, P. P.-B. C. A. R. D. P. D. C. D. P. S. E. L. L., Trallero, G., Merino, B. V., Pachón, I., & Sanz, C. (2004) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(04)73038-4 · Cited by 4
Trallero, G., Avellón, A., Otero, A., de Miguel, T., Alonso, M., & Pérez‐Breña, P. (2006) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13086549 · Cited by 4
ENVIRONMENTAL SURVEILLANCE OF POLIO AND NON-POLIO ENTEROVIRUSES IN SISTAN AND BALOUCHESTAN PROVINCE
Khodaei, S. H., Kargar, M., Tabatabaei, H., Sarijlou, M., & Nategh, R. (2008) · Iranian Journal of Public Health · Cited by 5
Romero, J. R., & Modlin, J. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00173-9 · Cited by 7
Bioinformatics analysis and genetic diversity of the poliovirus
Liu, Y., Ma, T., Liu, J., Zhao, X., Cheng, Z., Guo, H., Wang, S., & Xu, R. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.081992-0 · Cited by 4
“11 On: Mon, 17 Dec 2018 19:28:08 Immunization and the incidence rate of poliomyelitis has rapidly decreased (Kew et al., 2002).”
BackgroundInfluentialRe-emerging Diseases: Overview
Wilson, M. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00374-x · Cited by 4
Shulman, L. M. (2012) · Springer eBooks · doi:10.1007/978-1-4419-0851-3_839 · Cited by 5
Quasispecies dynamics in disease prevention and control
Domingo, E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816331-3.00008-8 · Cited by 3
“Escape mutants may be direct mutants of the infecting virus or may originate by recombination between the infecting virus and other coinfecting related viruses, as observed with poliovirus and bovine herpesvirus-1 [Kew et al., 2002; Thiry et al., 2006; among other studies].”
BackgroundOutbreak Response to Circulating Vaccine‐Derived Poliovirus in Three Northern Regions of Ghana, 2019
Odoom, J. K., Dzotsi, E. K., Nii-Trebi, N. I., Opare, D. A., Akyereko, E., Attiku, K. O., Duker, E. O., Eshun, M., Boahene, B., Gberbi, E., et al. (2024) · BioMed Research International · doi:10.1155/2024/5515777 · Cited by 3
“In countries such as Egypt [5], Hispaniola (Haiti and the Dominican Republic) [6], the Philippines [7], Myanmar and Madagascar [8], Indonesia [9], and China [10], outbreaks of cVDPVs have occurred and been successfully controlled.”
BackgroundDimitriou, T. G., Pliaka, V., Kyriakopoulou, Z., Ruether, I. G. A., Tsakogiannis, D., Fountoucidou, P., Gartzonika, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2013) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2013.10.004 · Cited by 3
Polio Vaccines: Present and Future
Chumakov, K., & Ishmukhametov, A. A. (2018) · Epidemiology and Vaccinal Prevention · doi:10.31631/2073-3046-2018-17-3-4-18 · Cited by 2
“Наглядным примером является случай первой вспышки цВРПВ на Гаити и в Доминиканской республике, которая оставалась незамеченной в течение полутора лет [41].”
Falleiros-Arlant, L. H., Avila-Aguero, M. L., del Castillo, J. B., de Gentile, A. S., Torres, J. R., & Debbag, R. (2022) · Revista chilena de infectología · doi:10.4067/s0716-10182022000500604 · Cited by 4
Nanteza, M. B., Bakamutumaho, B., Tushabe, P., Namuwulya, P., Birungi, M., Dhatemwa, R., Eliku, J. P., Tibanagwa, M., Kakooza, P., Bukenya, H., et al. (2023) · Virology Journal · doi:10.1186/s12985-023-02143-7 · Cited by 3
Cooper, L., Bandyopadhyay, A. S., Grassly, N. C., Gray, E. J., Voorman, A., Zipursky, S., & Blake, I. M. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae614 · Cited by 4
Romero, J. R. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch46 · Cited by 3
Determination of antigenic properties of vaccine derived poliovirus strains
Pliaka, V., Achilleos, C., Kyriakopoulou, Z., Tsakogiannis, D., Ruether, I. G. A., Gartzonica, C., Levidiotou-Stefanou, S., & Markoulatos, P. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.028 · Cited by 5
Protracted mumps encephalitis with good outcome
Kim, P., & Cappelen‐Smith, C. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.11.013 · Cited by 3
Seroprevalencia de anticuerpos contra el poliovirus 1 en niños mexicanos
Ruiz-Gómez, J., Valdespino, J. L., Olaiz-Fernández, G., Arias-Toledo, E., & Sepúlveda, J. (2007) · Salud Pública de México · doi:10.1590/s0036-36342007000900007 · Cited by 3
The lost decade of Global Polio Eradication and moving forward
Shimizu, H. (2010) · Uirusu · doi:10.2222/jsv.60.49 · Cited by 3
Self-citationWHO Polio Eradication Program: Problems and Solutions
Михайловна, Х. С., Pokrovsky, V. S., Александровна, Р. А., & Фридман, И. В. (2016) · Педиатрическая фармакология · doi:10.15690/pf.v13i3.1580 · Cited by 3
Guillou‐Guillemette, H. L., Pivert, A., Bouthry, E., Henquell, C., Petsaris, O., Ducancelle, A., Veillon, P., Vallet, S., Alain, S., Thibault, V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174651 · Cited by 3
Synthetic Biology Approaches for Vaccine Development
Shen, S. H., Futcher, B., Yang, C., & Wimmer, E. (2014) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.20120059 · Cited by 3
WHO global action plan for laboratory containment of wild polioviruses (Second edition)
Shimizu, H., Yoshida, H., & Miyamura, T. (2005) · Uirusu · doi:10.2222/jsv.55.161 · Cited by 6
Self-citationSecuring the Eradication of All Polioviruses
Grassly, N. C., & Orenstein, W. A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy651 · Cited by 3
Kockler, Z. W., Bostan, H., Klimczak, L. J., Hsiao, Y.-C., Dennen, M. S., Cook, M. E., Mertz, T. M., Perelygina, L. M., Kazanov, M. D., Li, J., et al. (2026) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkag080 · Cited by 4
Sharma, A. K., Verma, H., Estívariz, C. F., Bajracharaya, L., Rai, G., Shah, G., Sherchand, J. B., Jones, K. A. V., Mainou, B. A., Chavan, S. S., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00215-x · Cited by 4
“5 In 2000, an outbreak of circulating vaccine-derived poliovirus 1 highlighted that the Sabin-strain polioviruses in the oral poliovirus vaccine (OPV) could potentially revert and display the neurovirulence and transmissibility characteristics of WPV. 6,7 Because the continued use of the live-attenuated Sabin-strain p…”
Self-citationThe Development of Polio Vaccines: the Current Update (Review)
Ishmukhametov, A. A., Siniugina, A. A., & Chumakov, K. (2019) · Современные технологии в медицине · doi:10.17691/stm2019.11.4.22 · Cited by 2
“The discovery of circulating VAPP was made in the island of Haiti in 2000 [46].”
BackgroundRacaniello, V. R. (2016) · Springer eBooks · doi:10.1007/978-3-319-33133-1_1 · Cited by 4
Progresses Toward Polio Eradication in Asian Countries: Its History and Japan’s Contributions
Toizumi, M., Takamatsu, M., Toda, K., & Horikoshi, Y. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004478 · Cited by 2
Microarray Techniques for Evaluation of Genetic Stability of Live Viral Vaccines
Laassri, M., Cherkasova, E. A., Mones, S., & Chumakov, K. (2012) · InTech eBooks · doi:10.5772/25937 · Cited by 3
“…recombination (MAVR) assay, and microarray for quantitation of known virulent mutations (MQNVM) have been developed and applied as valuable tools to evaluate the genetic stability of live viral vaccines (Cherkasova et al., 2003; Laassri et al., 2011; Laassri et al., 2005; Laassri et al., 2007).”
BackgroundMethodInfluentialRacaniello, V. R. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541728.004 · Cited by 2
Gouandjika‐Vasilache, I., Burns, C. C., Gumede, N., Guillot, S., Ménard, D., Dosseh, A. R. G. A., Akoua-Koffi, C. G., Pallansch, M. A., Kew, O. M., & Delpeyroux, F. (2007) · Archives of Virology · doi:10.1007/s00705-007-0001-x · Cited by 2
“7 b[5-9-3] 150/140/110/80[5] 400/40/40 480 137/135/115/93 395/48/37 480”
MethodInfluentialSelf-citation¿Perlas del caribe? La salud pública en Haití y en Cuba
Castro, A., & Farmer, P. E. (2005) · Revista Colombiana de Antropología · doi:10.22380/2539472x.1227 · Cited by 2
“…de salud locales, los más grandes financiadores de la salud pública en América latina, con excepción de Cuba, son las agencias financieras internacionales tales como el Banco Mundial y, de manera menos directa, el Fondo Monetario Internacional (véanse los estudios de caso en Kim et al., 2000).”
BackgroundAssessment of areas at increased risk for poliovirus circulation in Ecuador
Dayan, G. H., Rodríguez, R., Vinjé, J., Vásconez, N., Cáceres, V. M., Gregoricus, N., Sobsey, M. D., & Landaverde, M. (2004) · Epidemiology and Infection · doi:10.1017/s0950268804002626 · Cited by 2
“During 2000–2001, 13 laboratory-confirmed poliomyelitis cases caused by a genetically drifted vaccinederived poliovirus (VDPV) type 1 were identified in the Dominican Republic, and 8 more cases were identified in Haiti [3].”
BackgroundSelf-citationPoliomielite – erradicação ou controle?
Rechenchoski, D. Z., de Godoi, A. M., Botura, T. J., Galhardi, L. C. F., Nozawa, C., & Linhares, R. E. C. (2016) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v14i2.13413 · Cited by 2
The Epidemiology of Poliomyelitis Deconstructed
Bhardwaj, S. (2016) · UC Merced Undergraduate Research Journal · doi:10.5070/m482030788 · Cited by 2
(2008) · The Internet Journal of Pediatrics and Neonatology · doi:10.5580/578 · Cited by 2
Murebwa-Chirambo, R., & Siziya, S. (2018) · Journal of Community Medicine & Health Education · Cited by 2
Influenza Virus, Enteroviruses, and Other Epidemic Viruses
(2014) · ASM Press eBooks · doi:10.1128/9781555817831.ch10 · Cited by 2
Minor, P. D., & Desselberger, U. (2020) · doi:10.1093/med/9780198746690.003.0083 · Cited by 2
Polio vaccines: hope, hype, and history repeating?
Fortner, R. S. (2023) · BMJ · doi:10.1136/bmj.p1763 · Cited by 2
Estívariz, C. F., Burns, C. C., & Macklin, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00050-5 · Cited by 4
Self-citationFirst Africa-based clinical trial for novel type 2 oral poliovirus vaccine
Cooper, L., & Blake, I. M. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00053-9 · Cited by 2
Boubaker, S., Ould-Mohamed-Abdallah, M. V., Benyahia, A., & Triki, H. (2009) · Pathologie Biologie · doi:10.1016/j.patbio.2009.01.004 · Cited by 3
Global Polio Eradication Program: Fundamental Lessons for the Control of Infectious Diseases
Miyamura, T. (2009) · Uirusu · doi:10.2222/jsv.59.277 · Cited by 2
Self-citationChapter 4 Enteroviruses with Special Reference to Poliovirus and Poliomyelitis Eradication
Hovi, T., Roivainen, M., & Blomqvist, S. (2007) · Perspectives in medical virology · doi:10.1016/s0168-7069(07)17004-x · Cited by 5
Should we use oral polio vaccine in Europe?
Lycke, E., Magnius, L. O., & Norder, H. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60514-6 · Cited by 2
Correction: Specific Capture and Whole-Genome Sequencing of Viruses from Clinical Samples
Depledge, D. P., Palser, A. L., Watson, S. J., Lai, I. Y.-C., Gray, E. R., Grant, P. R., Kanda, R. K., LeProust, E. M., Kellam, P., & Breuer, J. (2012) · PLoS ONE · doi:10.1371/annotation/3f1444bc-ab9d-4112-958a-2e068792f26f · Cited by 2
Romero, J. R. (2009) · Wiley eBooks · doi:10.1128/9781555815981.ch45 · Cited by 4
Relevance of Medical Ethics in Public Health: Case Study of Polio EradicationPreprint
John, T. J., & Dharmapalan, D. (2023) · Qeios · doi:10.32388/i8w77q · Cited by 2
Metadata
- Authors
- Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., Sutter, R., Tambini, G., Venczel, L., Pedreira, C., Laender, F., Shimizu, H., Yoneyama, T., Miyamura, T., van der Avoort, H., Oberste, M. S., Kilpatrick, D., Cochi, S., Pallansch, M., & de Quadros, C.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Caribbean Epidemiology Centre (CAREC) Laboratory, Pan American Health Organization (PAHO), 16-18 Jamaica Boulevard, Federation Park, Port-of-Spain, Trinidad and Tobago.
- World Health Organization Regional Office for the Americas (US)
- Ministry of Health, Avenida San Cristóbal esquina Tiradentes, Santo Domingo, Dominican Republic.
- Ministry of Public Health, Port-au-Prince, Haiti.
- PAHO, Calle Pepillo Salcedo, Plaza de la Salud, Santo Domingo, Dominican Republic.
- PAHO, Number 295 Avenue John Brown, Port-au-Prince, Haiti.
- National Institute of Infectious Diseases (JP)
- Polio Laboratory, National Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 BA, Bilthoven, Netherlands.
- Division of Vaccines and Immunization, PAHO, 525 Twenty-Third Street, N.W., Washington, DC 20037, USA.
- Corresponding author
- Kew, Olen
- ORCID
- Venue
- Science
- Published
- 2002-04-12
- Volume
- 296
- Issue
- 5566
- Pages
- 356-359
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101037145
- Cited by
- 600
- References
- 19
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 15 · 2023: 19 · 2022: 20 · 2021: 15 · 2020: 17 · 2019: 17 · 2018: 21 · 2017: 21 · 2016: 26 · 2015: 22 · 2014: 39 · 2013: 26 · 2012: 26
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- poliomyelitis outbreak, vaccine-derived poliovirus, poliovirus type 1, oral polio vaccine, Hispaniola, Dominican Republic, Haiti, unvaccinated children, low vaccination coverage, paralytic poliomyelitis, wild poliovirus
- MeSH terms
- Adolescent, Animals, Capsid, Child, Child, Preschool, Disease Outbreaks, Dominican Republic, Female, Genes, Viral, Haiti, Humans, Infant, Male, Molecular Sequence Data, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Recombination, Genetic, Vaccination, Virulence, Point Mutation, Immunization Programs, Poliovirus, 5' Untranslated Regions, Capsid Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.